CYP19A1 and ovarian cancer: We have previously reported that knockdown of BRCA1 in ovarian granulosa cells results in elevated aromatase basal expression, providing a molecular explanation for why loss of BRCA1 predominantly leads to breast and ovarian cancers in women (8).